20 years of experience with tumour necrosis factor inhibitors: what have we learned?
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology"
DOI: 10.1093/rheumatology/key059
Abstract: TNF inhibitors are biologic DMARDs approved for the treatment of active RA in mid-1990s. They still represent a valuable therapeutic option to control the activity, disability and radiographic progression of the disease. In the context… read more here.
Keywords: years experience; factor inhibitors; experience tumour; tumour necrosis ... See more keywords